STAT
SEPTEMBER 6, 2024
This is a developing story and will be updated. A person in Missouri who didn’t report any contact with animals has tested positive for H5 bird flu, the state’s Department of Health and Senior Services and the Centers for Disease Control and Prevention said Friday. It’s not yet clear if the person was infected with the same virus strain that’s causing the ongoing outbreak among dairy cattle.
PharmaVoice
SEPTEMBER 6, 2024
The factors driving the industry’s layoffs — and what could help turn the tide.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 6, 2024
As the mom of three young adults, I am worried about their economic future — their ability to get jobs and afford homes. But I am equally concerned about their mental health and well-being. A 2022 national survey found that approximately half of young people ages 18-25 have a mental illness, substance use disorder, or both. Suicide and overdose rates remain persistently high: As Nicholas Kristof has written, “every three or four days we lose as many Americans to drugs, alcohol and
Express Pharma
SEPTEMBER 6, 2024
Immuneel Therapeutics a cell and gene therapy platform, announced the appointment of Amit Mookim as its new Chief Executive Officer. He brings over two decades of experience across life sciences, technology and private equity, making him ideally suited to lead Immuneel into its next phase of growth and innovation. Mookim joins Immuneel from IQVIA, a Fortune 500 in clinical research, technology and analytics, where he served as Managing Director for South Asia.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
SEPTEMBER 6, 2024
Private equity firms are leading the buyout of R1 RCM , a major provider of billing and administrative services for hospitals and physician groups. But R1’s hospital customers — some of the biggest systems in the country — were influential in steering the company to that outcome. Ascension, a nonprofit Catholic health system, is R1’s largest client and biggest shareholder through an investment fund with private equity firm TowerBrook Capital Partners.
Pharmaceutical Business Review
SEPTEMBER 6, 2024
This recommendation will aid in the potential authorisation of the vaccine for use in individuals aged six months and older to prevent Covid-19 in the upcoming 2024-2025 autumn/winter season. The CHMP’s positive opinion is grounded in a comprehensive evaluation, including manufacturing and preclinical data, as well as earlier clinical, non-clinical, and real-world evidence confirming the vaccine’s efficacy and safety.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
pharmaphorum
SEPTEMBER 6, 2024
GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.
STAT
SEPTEMBER 6, 2024
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Hello! Timmy here. I will be spending ten hours on Sunday carrying my wonderfully chaotic niece on my shoulders while she points at mascots at Kings Island amusement park. Please pray for my shoulders!
Express Pharma
SEPTEMBER 6, 2024
Strides Pharma Science announced that its step-down wholly owned subsidiary, Strides Pharma Global, Singapore, has received approval for the generic version of Theophylline Extended-Release Tablets, 300 mg and 450 mg, from the United States Food and Drug Administration (USFDA). The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), THEO-DUR, of Schering Corp.
STAT
SEPTEMBER 6, 2024
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up. As always, we plan to promenade with the official mascots and catch up on our reading, although we also expect to entertain a traveler. On that note, we are planning another listening party, where the rotation will likely include this , this , this , this , and this.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
The Pharmacist
SEPTEMBER 6, 2024
The UK medicines regulator has warned that men taking valproate and their partners should use effective contraception, because of a small increased risk of harm to children if the drug is used by a father at conception. Healthcare professionals should inform male patients about this ‘newly identified risk’ at their next routine treatment review and […] The post MHRA warns men taking valproate to use contraception over small risk to children appeared first on The Pharmacist.
STAT
SEPTEMBER 6, 2024
Laurie Glimcher stunned Boston’s medical world last September by orchestrating Dana-Farber Cancer Institute’s breakup with its longtime partner, Brigham & Women’s, so her institution could build its own free-standing hospital. Now Glimcher has made another bold pronouncement: On Oct. 1, she will step down as Dana-Farber’s CEO, and let someone else implement her vision.
Pharmaceutical Technology
SEPTEMBER 6, 2024
The US FDA has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD-147 aimed at neuroendocrine carcinoma.
The Pharmacist
SEPTEMBER 6, 2024
An ongoing funding shortfall has left pharmacies in a ‘hole’ they are struggling to get out of, parliamentarians have been told as part of an event hosted by the Independent Pharmacies Association (IPA). MPs and peers were also warned that Pharmacy First thresholds are 'unrealistic', while concerns were raised about the scheme's reliance on GP […] The post Funding shortfall leaves pharmacies ‘stuck in a hole’, IPA tells MPs appeared first on The Pharmacist.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Express Pharma
SEPTEMBER 6, 2024
Akums Drugs and Pharmaceuticals has announced the appointment of Shantanu R Chobhe as the Corporate Quality Assurance Head. At Akums, Chobhe will take charge of all quality assurance (QA) and quality control (QC) departments, overseeing both active pharmaceutical ingredients (API) and formulations. His deep expertise in quality management and regulatory affairs will be critical as Akums continues to uphold its commitment to delivering high-quality pharmaceutical products.
pharmaphorum
SEPTEMBER 6, 2024
Financings in the biotech sector this week include an IPO filing for BioAge and private rounds for eGenesis, Navigator, and Circle Pharma.
Express Pharma
SEPTEMBER 6, 2024
Sun Pharmaceutical Industries (and its subsidiaries or associate companies) and Israel-based Moebius Medical announced that the US Food and Drug Administration (FDA) has granted Fast Track designation (FTD) to MM-II (Large Liposomes of DPPC and DMPC) for the treatment of osteoarthritis knee pain. Planning for confirmatory Phase 3 clinical trials for MM- II is underway.
pharmaphorum
SEPTEMBER 6, 2024
The fallout from the FDA's recent decision not to approve Lykos Therapeutics' psychedelic treatment has spread to its senior management, with chief executive Amy Emerson stepping down.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharma Times
SEPTEMBER 6, 2024
New treatment could simplify diabetes management for millions
EMCrit Project
SEPTEMBER 6, 2024
Learn about how to use ultrasound during cardiac arrest EMCrit Project by Scott Weingart, MD FCCM.
Pharmaceutical Technology
SEPTEMBER 6, 2024
The US FDA has approved Amneal Pharmaceuticals and Shilpa Medicare’s oncology product BORUZU for subcutaneous administration.
pharmaphorum
SEPTEMBER 6, 2024
Embracing diversity in psychiatry and neurology clinical trials is crucial for ensuring that treatments are effective for all populations. Learn about the importance of diversity in clinical trials and how to promote inclusivity in research.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Pharmacist
SEPTEMBER 6, 2024
NHS England (NHSE) has published a pathway for community pharmacies to follow if a patients presents with suspected mpox. If a clinical assessment is required to determine if the patient is a possible or probable case, they should be assessed remotely – for instance, on the phone, NHSE said. And staff should not physically assess […] The post NHSE publishes guidance for community pharmacies dealing with suspected mpox appeared first on The Pharmacist.
pharmaphorum
SEPTEMBER 6, 2024
Eli Lilly signs another genetic medicines deal, this time with Genetic Leap, a start-up that applies AI to the discovery of RNA-targeted drugs.
World Pharma News
SEPTEMBER 6, 2024
Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept. 4 in Nature, goes a step beyond many current AI approaches to cancer diagnosis, the researchers said. Current AI systems are typically trained to perform specific tasks - such as detecting cancer presence or predicting a tumor's genetic profile - and they tend to work only in a handful of canc
pharmaphorum
SEPTEMBER 6, 2024
Understanding the impact of Medtech regulations on balancing innovation and safety is crucial for the industry. Discover how compliance with regulations plays a vital role in fostering innovation while ensuring patient safety in the field of medical technology.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
BioPharma Dive
SEPTEMBER 6, 2024
OrsoBio is advancing several weight loss medicines. Elsewhere, Boehringer Ingelheim pushed forward with a geographic atrophy drug and Vaxcyte raised $1.3 billion.
Viseven
SEPTEMBER 6, 2024
Data is everywhere. No matter how big your company is or what its main services or products are, it’s likely that it relies on data for daily operations. Good record management practices, quality risk management, and robust compliance frameworks are standard procedures in industries like pharmaceuticals and life sciences. All of it is done to assure data integrity—the glue that holds together all measures and actions performed to keep the data safe, error-free, and complete.
BioPharma Dive
SEPTEMBER 6, 2024
New trial results could offer support for an expansion of Nucala’s label after U.S. regulators rejected GSK’s submission in 2018.
Proxsys Rx
SEPTEMBER 6, 2024
Week One: Tallahassee, Florida. Training at the pharmacy. Week Two: Holyoke, Massachusetts. Training at the pharmacy. Week Three: Houma, Louisiana. Training at the pharmacy. Week Four: Home. You’d think, at some point, that a life spent mostly on the road — living out of a suitcase, repeating the same processes week-in and week-out — might become something of a dull, dispiriting grind for this grandmother of two.
European Pharmaceutical Review
SEPTEMBER 6, 2024
Results from a Phase I/II gene therapy trial have demonstrated that ATSN-101 enabled patients with a rare inherited disease to gain substantial, rapid improvement in their vision. Participants with Leber congenital amaurosis (LCA1) due to mutations in the GUCY2D gene were evaluated in the one-year clinical trial. Of the 15 participants, three were paediatric subjects.
Expert insights. Personalized for you.
364 
Let's personalize your content